Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-IFN-SA in Chronic Hepatitis C
NCT01908335Phase 2Completed
- Sponsor
- Beijing Kawin Technology Share-Holding Co., Ltd.
- Start
- Oct 2012
- Primary completion
- Aug 2013
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2a in hepatitis C (HCV), sponsored by Beijing Kawin Technology Share-Holding Co., Ltd.. Started Oct 2012; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01908335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01908335.